Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 107 citing articles:

Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants
Ashley C. Beavis, Li Zhuo, Kelsey Briggs, et al.
Journal of Virology (2025)
Open Access
Development of Nasal Vaccines and the Associated Challenges
Xuanxuan Nian, Jiayou Zhang, Shihe Huang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 1983-1983
Open Access | Times Cited: 26
A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern
Jingyi Yang, Meiqin Liu, Lin Liu, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 11, pp. 1279-1289
Open Access | Times Cited: 26
Nasal delivery as a strategy for the prevention and treatment of COVID-19
Fabio Sonvico, Gaia Colombo, Eride Quarta, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 8, pp. 1115-1130
Open Access | Times Cited: 13
Nanoparticles and Antiviral Vaccines
Sen L, Meilin Hu, Xiaoqing Liu, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 30-30
Open Access | Times Cited: 13
Secretory IgA and course of COVID-19 in patients receiving a bacteria-based immunostimulant agent in addition to background therapy
М. П. Костинов, О. А. Свитич, А. Г. Чучалин, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Intranasally Inoculated SARS-CoV-2 Spike Protein Combined with Mucoadhesive Polymer Induces Broad and Long-Lasting Immunity
Tomoko Honda, Sakiko Toyama, Yusuke Matsumoto, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 794-794
Open Access | Times Cited: 4
Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in Mice
Anna-Polina Shurygina, Marina A. Shuklina, Olga O. Ozhereleva, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 58-58
Open Access
Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
Ming Zhou, Haihua Xiao, Xinyi Yang, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibility
Mengxin Xu, Zhaoyong Zhang, Yuzhu Sun, et al.
Antiviral Research (2025) Vol. 235, pp. 106082-106082
Closed Access
Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens
Yen Thi Kim Nguyen, Xueyong Zhu, Julianna Han, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 7
Open Access
Next-Generation Coronavirus Disease 2019 Vaccines
Kathryn E. Stephenson
Infectious Disease Clinics of North America (2025)
Closed Access
A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3–17 years
Kai Chu, Jiali Quan, Xiaohui Liu, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
An intranasally administered adenovirus-vectored SARS-CoV-2 vaccine induces robust mucosal secretory IgA
Baoqing Sun, Qian Wang, Peiyan Zheng, et al.
JCI Insight (2024) Vol. 9, Iss. 18
Open Access | Times Cited: 3
Tailoring Light–Matter Interactions in Overcoupled Resonator for Biomolecule Recognition and Detection
Dongxiao Li, Hong Zhou, Zhihao Ren, et al.
Nano-Micro Letters (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Cellular basis of enhanced humoral immunity to SARS-CoV-2 upon homologous or heterologous booster vaccination analyzed by single-cell immune profiling
Jingwen Ai, Jingxin Guo, Haocheng Zhang, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 18
Nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Felicity Liew, Shubha Talwar, Andy Cross, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 17
A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice
Ryan R. Chaparian, Alfred T. Harding, Cait E. Hamele, et al.
Journal of Virology (2022) Vol. 96, Iss. 15
Open Access | Times Cited: 16
From Co-Administration to Co-Formulation: The Race for New Vaccines against COVID-19 and Other Respiratory Viruses
Daniele Focosi
Vaccines (2023) Vol. 11, Iss. 1, pp. 109-109
Open Access | Times Cited: 10
Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD
Yulei Li, Peipei Liu, Tianjiao Hao, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 9
Safety, immunogenicity, and protective effective of inhaled COVID‐19 vaccines: A systematic review and meta‐analysis
Song Gao, Rong Li, Meng-Qun Cheng
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Open Access | Times Cited: 3
Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models
Tobias Freitag, Riku Fagerlund, Nihay Laham-Karam, et al.
Vaccine (2023) Vol. 41, Iss. 20, pp. 3233-3246
Open Access | Times Cited: 8
Oral delivery of a chitosan adjuvanted COVID-19 vaccine provides long-lasting and broad-spectrum protection against SARS-CoV-2 variants of concern in golden hamsters
Shen Wang, Huan Cui, Cheng Zhang, et al.
Antiviral Research (2023) Vol. 220, pp. 105765-105765
Closed Access | Times Cited: 8
Mucosal vaccine development for respiratory viral infections
Yifan Lin, Zhenxiang Hu, Yang–Xin Fu, et al.
hLife (2023) Vol. 2, Iss. 2, pp. 50-63
Open Access | Times Cited: 8
Viral-vectored respiratory mucosal vaccine strategies
Mangalakumari Jeyanathan, Sam Afkhami, Alisha Kang, et al.
Current Opinion in Immunology (2023) Vol. 84, pp. 102370-102370
Closed Access | Times Cited: 7

Scroll to top